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Determining cell identity and maturation status of differentiated pluripotent stem cells
(PSCs) requires knowledge of the transcriptional and epigenetic trajectory of organs during
development. Here, we generate a transcriptional and DNA methylation atlas covering 21
organs during human fetal development. Analysis of multiple isogenic organ sets shows that
organ-specific DNA methylation patterns are highly dynamic between week 9 (W9) and
W22 of gestation. We investigate the impact of reprogramming on organ-specific DNA
methylation by generating human induced pluripotent stem cell (hiPSC) lines from six iso-
genic organs. All isogenic hiPSCs acquire DNA methylation patterns comparable to existing
hPSCs. However, hiPSCs derived from fetal brain retain brain-specific DNA methylation
marks that seem sufficient to confer higher propensity to differentiate to neural derivatives.
This systematic analysis of human fetal organs during development and associated isogenic
hiPSC lines provides insights in the role of DNA methylation in lineage commitment and
epigenetic reprogramming in humans.
DOI: 10.1038/s41467-017-01077-3 OPEN
1 Department of Anatomy and Embryology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands. 2Molecular Epidemiology
Section, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands. 3 Department of Molecular Cell Biology, Leiden University
Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands. 4 Department of Nephrology, Leiden University Medical Center, Albinusdreef 2, 2333
ZA Leiden, The Netherlands. 5 Hubrecht Institute, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands. 6 Department for Reproductive Medicine, Ghent
University Hospital, De Pintelaan 185, 9000 Ghent, Belgium. Roderick C. Slieker and Monika Bialecka contributed equally to this work. Correspondence and
requests for materials should be addressed to S.M.Cd. S.L. (email: lopes@lumc.nl)
NATURE COMMUNICATIONS |8:  908 |DOI: 10.1038/s41467-017-01077-3 |www.nature.com/naturecommunications 1
Every organ in the body has a core, organ-specific tran-scriptional signature that ultimately determines the shapeand functionality of each organ and ensures that this
remains stable throughout the life of the organism. Whilst much
has been published on organ-specific transcriptional and epige-
netic landscapes in laboratory animals and stem cell models
in vitro, equivalent comprehensive data using a large set of
human organs from the same individual (isogenic analysis), that
circumvents genetic differences confounding the outcome, has
not been performed to date1–12.
Setting the correct patterns of DNA methylation is crucial
during development, but removing those during the reverse
process of reprogramming somatic cells from any human tissue
to pluripotency as induced pluripotent stem cells (iPSCs)13, 14 is
also important. Reprogramming is accompanied by extensive
epigenetic remodeling, which results in a pluripotent state com-
parable to that of embryonic stem cells (ESCs)15, 16. However,
although the gene expression signatures of iPSCs and ESCs are
similar, when large numbers of lines are compared, individual
lines are not necessarily identical17–20. This led to the hypothesis
that residual epigenetic memory may be retained from the tissue
of origin. Indeed, it was demonstrated that mouse and human
iPSCs harbor some features of the tissue of origin, i.e. histone
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W16-18 3 1 0 1 1 1 1 0 1 1 1 3 1 3 1 1 1 1 3 1 1 0
W20-22 2 2 2 0 1 2 2 0 3 2 2 2 2 1 0 2 1 2 2 2 1 1
W16-18 3 1 3 0 2 2 3 0 2 2 2 2 2 1 2 2 2 2 2 2 3 1
W20-22 2 1 2 0 2 1 2 0 2 2 2 2 2 3 2 2 2 2 3 1 2 0
W8-12 3 1 2 1 2 1 2 1 2 2 2 3 2 3 2 2 2 2 3 1 2 0




















































































Fig. 1 Transcriptional and DNA methylation of a collection of organs of first and second trimester. a The collection of 111 samples analysed for gene
expression (by next generation sequencing (NGS) DeepSAGE) and 105 samples analysed for DNA methylation (by Illumina 450 K array). See also
Supplementary Data File 1. Mat, maternal. b Multidimensional scaling (Euclidian distance) of the transcriptional profiles of the 111 samples. The colors
represent the different germ layers whereas the shapes indicate the gestational age. See also Supplementary Fig. 2a. c Multidimensional scaling
(Euclidian distance) of the DNA methylation profiles of the 105 samples. The colors represent the different germ layers whereas the shapes indicate
the gestational age. See also Supplementary Fig. 2b. d Hierarchical clustering (Euclidian distance) of the 105 DNA methylation samples. eMultidimensional
scaling (Euclidian distance) of the DNA methylation profiles excluding the extraembryonic samples. The colors represent the different germ layers
whereas the shapes indicate the gestational age. Dashed arrows represent the trend of DNA methylation dynamics during development in similar
organs
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can favor differentiation towards the lineage from which they
were derived21–29. The main contribution to the variation
between hiPSCs and hESCs has also been suggested to be the
genetic background instead of epigenetic memory16, 30, 31.
However, data to distinguish between these two possibilities is
currently lacking. An intriguing difference between mouse and
human iPSCs is that the epigenetic memory of mouse iPSCs is
lost during continuous passage in culture, whereas human iPSCs
appear to have more persistent epigenetic marks26, 28. Under-
standing how these factors influence the differentiation capacity
of iPSCs would help determine a better framework for the use
iPSCs in disease modeling, drug screening and regenerative
medicine.
We have determined the transcriptional profiles of human fetal
organs from the first and second trimester of development and
identified a set of core organ-specific genes or “key genes” (also
referred to as classifier genes) that were highly expressed in the
organ it identifies, often from as early as 9 weeks of gestation
(W9)7. In contrast to the organ-specific transcriptional identity,
the core organ-specific pattern of DNA hypomethylation, that
remains stable throughout adulthood, takes longer to be estab-
lished. More precisely, between W9 and W22 the general
development-related programs gain DNA methylation and are
shutdown, whereas organ-specific genetic programs associated
with organ functionality lose DNA methylation8. The DNA
methylation pattern observed at W22 in some organs appears at
least in part to be maintained during adulthood32–35, suggesting
lineage commitment.
Here, we present a comprehensive analysis of human fetal
DNA methylation and corresponding genome-wide transcription
data: the analysis includes 21 human fetal organs (plus maternal
endometrium) from different fetuses (N= 18) at W8-12, W16-18
and W20-22. Furthermore, we used this material to overcome one
of the major challenges to assess epigenetic memory in human
iPSCs with different origins by generating lines from six isogenic
fetal organs (brain, skin, kidney, muscle, lung and pancreas). For
all organs, we used the same primary cell isolation method, cul-
ture protocol and reprogramming conditions in order to rule out
any confounding factors. We compared the DNA methylation
profiles of hiPSCs to their organs of origin and showed that
hiPSCs derived from fetal brain retain brain-specific DNA
methylation marks that led to a higher propensity to differentiate
to neural derivatives. This exemplifies how very small differences
in DNA methylation may result in different propensity of hiPSCs
to differentiate.
Results
Human fetal transcriptional and DNA methylation trajec-
tories. We analyzed DNA methylation (n= 105 samples; Illumina
450 K array) and, if available, the corresponding genome-wide
transcriptional data (n= 111 samples; NGS DeepSAGE) from 21
different organs from N= 18 human fetuses at three different
time points during gestation W8-12, W16-18 and W20-22
(Fig. 1a and Supplementary Data File 1). 34 of 105 samples of
the DNA methylation dataset and the whole transcriptional
dataset have been generated previously by us7, 8 (Fig. 1a).
After quality control (Supplementary Fig. 1), we applied
multidimensional scaling (MDS) to the 111 NGS datasets and
found that the four directions towards the corners of the MDS
plot corresponded to the germ layers (Fig. 1b and Supplementary
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Fig. 2 Organ-specific upregulated and downregulated genes and associated changes in DNA methylation. a Numbers of differentially expressed genes
(FDR< 0.01, general linearized model) between W8-12 and W20-22 in different organs. Heart V, heart ventricle; Mother, maternal endometrium. b
Heatmap of the upregulated genes that were uniquely assigned to one organ. See also Supplementary Data File 2. c Heatmap of the downregulated genes
that were uniquely assigned to one organ. See also Supplementary Data File 2. d Boxplots illustrating the organ-specific methylation changes (delta beta) of
the nearest proximal promoter (PP) and the gene body (GB) of the loci identified in b, c, excluding the maternal endometrium. The red line indicates a delta
beta of −0.3, 0 and 0.3. See also Supplementary Data File 3
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(endoderm), the brain/spinal cord samples (ectoderm), muscle/
heart/tongue samples (mesoderm) and the placenta/chorion/
amnion/umbilical cord samples (extraembryonic) towards the
periphery of the MDS plot (Fig. 1b and Supplementary Fig. 2a).
However, although similar organs often clustered together
forming their own spatial domains, many organs intermingled
in the center of the MDS plot showing limited separation, in
particular organs with mixed origin (pancreas, intestine, lung
adrenal) (Supplementary Fig. 2a).
Next, we performed similar MDS analysis and hierarchical
clustering based on Euclidian distance using the sample-matched
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tissues, chorion and placenta, exhibited a fundamentally different
DNA methylation pattern from the other (embryonic) organs.
They clustered separately (Fig. 1c, d) and showed distinctive high
levels of intermediate DNA methylation on autosomes (Supple-
mentary Fig. 1d), previously also described in human term
placenta36. On the dendrogram, some organs clustered in an
organ-specific manner, independently of their developmental age
(brain/eye, liver, heart ventricle/atrium, gonad, kidney and lung)
and this was similar to the organ-specific clustering observed on
the basis of the transcriptome; while other organs including
tongue/muscle, stomach/intestine/pancreas, adrenal and skin,
clustered at W8-12, separating only at W16-22 in distinct
organ-specific clusters. To increase resolution, we then performed
a MDS analysis on the DNA methylation dataset excluding the
extraembryonic tissues and confirmed the strong dynamics of
DNA methylation between W8-22, in contrast to the more stable
tissue-specific transcriptome during the same developmental
period (Fig. 1e and Supplementary Fig. 2b).
Small correlation between transcription and DNA methylation.
Next, we investigated the presence of differentially expressed
genes or DEGs (upregulated and downregulated) between W8
and W22 per organ (FDR< 0.01; general linearized model)
(Fig. 2a). After that, we filtered the DEGs that were organ-specific
and had a log-fold change (logFC)> 1 or logFC< −1 (Fig. 2b, c
and Supplementary Data File 2). Interestingly, the number of
organ-specific DEGs (excluding X-linked genes to avoid sex bias)
was small, with the exception of the upregulated (up-)DEGs in
the intestine (n= 203) and maternal endometrium (n= 146).
Surprisingly, some organs, like the lung, showed no organ-specific
DEGs between W8-22 and many others (liver, pancreas, stomach,
kidney and muscle) showed less than 10 organ-specific DEGs,
suggesting that either between W8-22 the transcriptional state of
the organ-specific progenitors remains similar within each organ
or that, alternatively, the bulk sequencing of the organ is masking
the cellular maturation of organ-specific progenitors.
We examined whether the changes in expression of
organ-specific DEGs were accompanied by changes in DNA
methylation in their respective loci. This was done by plotting the
calculated differences in beta values between W8-12 and W20-22
(delta beta) of the CpGs in the proximal promoters (PP)
(−1.5 Kb to + 0.5Kb) and gene bodies (GB) ( + 0.5Kb to
3′ untranslated region (UTR)) of the identified organ-specific
up-DEGs and down-DEGs (Fig. 2d and Supplementary Data
File 3). Overall, a direct correlation between organ-specific
transcriptional up- and downregulation and changes in DNA
methylation was in most organs not existent or very modest.
However, the reduced number of organ-specific down-DEGs was
still sufficient to be associated with an increase in DNA
methylation (positive delta beta) in their PP and a decrease
(negative delta beta) in their GB in eye, liver and muscle (Fig. 2d).
By contrast, organ-specific up-DEGs were accompanied by a
modest decrease of DNA methylation (negative delta beta) in
their PP in amnion, eye, pancreas, tongue and muscle; but an
increase (positive delta beta) in their GB only in amnion, eye and
pancreas (Fig. 2d).
Exemplifying the association between gene expression and
DNA methylation, two CpGs in the PP of the muscle up-DEG
C8orf2, also shown by others to be overexpressed in skeletal
muscle37, showed reduced levels of DNA demethylation between
W8-12 and W20-22 (−0.31 and −0.19 of delta beta). In the brain,
up-DEG GFAP, important in the development of the central
nervous system38, 39 and up-DEG CHRM1, important in
schizophrenia40, showed pronounced demethylation in their PP
between W8-12 and W20-22. The PP of GFAP contained five
CpGs that underwent demethylation (−0.50, −0.43, −0.42, −0.36,
−0.35 of delta beta) and the PP of CHRM1 contained four CpGs
that were demethylated (−0.34, −0.26, −0.24, −0.16 of delta beta).
In the eye, we observed increased methylation in five CpGs in the
PP ( + 0.19, + 0.17, + 0.17, + 0.13 and + 0.11 of delta beta) and
increased demethylation in two CpGs in the GB (−0.2 and −0.13
of delta beta) of eye down-DEGs CRYBB3 and CRYBA1, which
are structural components of crystalline, between W8-12 and
W20-22.
Isogenic human organs have specific DNA methylation pat-
terns. One of the unique features of our datasets is the isogenic
nature of many sets of organs (Supplementary Data File 1) and in
particular three sets of DNA methylation of 14 organs from a W9
male, W18 female and W21 male (Fig. 3a). This enabled us to
compare the methylation status of individual CpG between iso-
genic organs with the assurance that any difference in DNA
methylation would be entirely attributable to differences between
the organs (Fig. 3a and Supplementary Fig. 3a).
We identified hypermethylated and hypomethylated CpGs,
defined as a pairwise (organ of interest versus all others of the
isogenic set) difference in beta values of > 0.2 or< 0.2,
respectively, a cut-off that we have shown previously to be
sufficient to highlight differences between different organs8
(Fig. 3b–d and Supplementary Fig. 3b,c). The placenta was part
of the isogenic W9 and W21 sets and showed high numbers of
hypermethylated and hypomethylated CpGs (W9: 19439 and
39634 CpGs, W21: 13260 and 22311 CpGs, respectively)
compared to the other organs (Supplementary Fig. 3b,c),
most likely reflecting its extraembryonic origin. Therefore, we
generated separate plots excluding the hypermethylated and
hypomethylated CpGs of the placenta (Fig. 3b, d).
The number of organ-specific hypomethylated CpGs was
consistently higher than the number of hypermethylated CpGs
(Supplementary Fig. 3d), highlighting the importance of hypo-
methylation as a distinguishing feature between organs5, 8, 41. In
most individual organs (excluding the placenta), the number of
organ-specific hypermethylated and hypomethylated CpGs
increased between W9 and W21 (Fig. 3e and Supplementary
Fig. 3d), suggesting progression in organogenesis and lineage
commitment.
Fig. 3 DNA methylation signatures of isogenic sets of organs. a Violin plots showing the distribution of the DNA methylation (beta values) in each of the 14
isogenic organs at W9, W18 and W21. Heart A, heart atrium; Heart V, heart ventricle; Sp. cord, spinal cord. b–d Heatmaps illustrating hyper- (top) and
hypomethylated (bottom) CpGs per organ with a beta value difference of> 0.2 or< 0.2, respectively, at W9 b, W18 c and W21 d. Due to the quantity of
hypermethylated and hypomethylated CpGs in the placenta at W9 and W18, those were removed but are given in Supplementary Fig. 3b, c. e Venn
diagram illustrating the overlap of the hypermethylated (bottom) and hypomethylated (top) CpGs of the organs at W9 and W21. The numbers in brackets
represent the CpGs including the placenta. The overlapping CpGs per organ are given in Supplementary Fig. 3d. f Genic and CGI-centric annotation of the
identified hyper- (left) and hypomethylated (right) CpGs given as odds ratio (OR). CGI, CpG island; DP, distal promoter; GB, gene body; IG, intergenic; NC,
non-CGI; PP, proximal promoter; SHE, shelf; SHO, shore. g Number of organ-specific hypermethylated and hypomethylated differentially methylated
regions (DMRs) per isogenic organ. Tongue and muscle were pooled. For the nearest associated loci see Supplementary Data File 4.The number of
organ-specific hypermethylated and hypomethylated individual CpGs are given in brackets
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Fig. 4 Epigenetic memory of isogenic human iPSCs from six organs a Illustration describing the experimental setup for reprogramming. OSKM,
reprogramming factors POU5F1, SOX2, KLF4, MYC. b Bright-field pictures of the primary cells (first row, scale bar 50 µm) and the iPSC colonies of clone #1
(second row, scale bar 1 mm) from the six organs. The iPSCs (clones #1) were immunostained for POU5F1 and TRA-1-81 (third row, scale bar 100 µm)
and NANOG and SSEA4 (fourth row, scale bar 100 µm). For the single channels and the immunostaining of clones #2 see Supplementary Fig. 4a.
c Real-time quantitative PCR analysis of the 12 iPSCs for endogenous SOX2, endogenous OCT4 and NANOG. NKX2.5eGFP/w hESCs were used as positive
and fetal skin as negative control. Each bar represents the mean of three technical replicates± standard deviation. d Violin plots depicting the distribution
of the DNA methylation (beta values) of the 12 iPSCs and their isogenic organ of origin. e Hierarchical clustering of the 12 iPSCs and their isogenic organ of
origin based on the DNA methylation profiles. f Heatmap of uniquely hypermethylated (top) and hypomethylated (bottom) CpGs in the 12 iPSCs compared
to the six organs of origin with a beta value difference of> 0.2 or< 0.2, respectively. See also Supplementary Data File 5. g Heatmap depicting uniquely
hypermethylated (top) and hypomethylated (bottom) CpGs in the brain triplet (two iPSC clones and brain) compared to the five triplets with a beta value
difference of > 0.2 or< 0.2, respectively. The genic location and gene identity are provided
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We investigated the genomic location of the organ-specific
hypermethylated and hypomethylated CpGs identified (including
the placenta) per developmental stage. The organ-specific
hypermethylated CpGs were mainly associated with CpG islands
(CGIs) and their shores, but only downstream regions (p< 0.5 ×
10−10; chi-squared test) showed significant enrichment at all three
time points. By contrast, the organ-specific hypomethylated CpGs
were enriched in non-CGI regions and CGI-shelves consistently
at all three time points, particularly when they are associated with
distal promoters (p< 0.5 × 10−10; chi-squared test) and down-
stream regions (p< 0.005; chi-squared test) (Fig. 3f). Using the
chromatin state segmentations for the available organs from the
Epigenomics Roadmap Project42, the identified hypomethylated
CpGs were enriched at enhancers confirming previous studies
with less organs8 (Supplementary Fig. 3e). Hypermethylation on
the other hand was rather associated with repressed Polycomb
regions and bivalent TSS and bivalent enhancers (Supplementary
Fig. 3e).
In addition to DNA methylation changes in single CpGs in the
isogenic datasets, we also inferred the organ-specific differentially
methylated regions (DMRs), defined as three consecutive
hypermethylated or hypomethylated CpGs within 1Kb of each
other, applying a widely-used algorithm35 (Fig. 3g). Considering
the limited number of organ-specific hypermethylated and
hypomethylated CpGs at W9, many W9 organs contained no
organ-specific DMRs (Fig. 3g). However, the number of organ-
specific DMRs increased between W9 and W21, and in the
second trimester each organ showed at least one organ-specific
DMR (Fig. 3g). The skeletal muscle and tongue, both muscular
organs, showed similar DNA methylation patterns and were
therefore pooled. The organ-specific DMRs were mapped to their
nearest loci (Supplementary Data File 4) and, interestingly, many
identified loci showed biological relevance for the corresponding
organ. At W21, one of the intestine hypomethylated DMRs was
mapped to TFF1, a gene that has been reported to be
downregulated via DNA methylation in gastric cancer43. The
stomach at W21 on the other hand harbored a hypermethylated
DMR associated with NKX3-2, which is thought to be involved in
stomach development44.
Isogenic set of human iPSCs from six different W21 organs.
After determining the trajectory of DNA methylation during
(isogenic) lineage commitment in development, we investigated
the direct effects of reprogramming cells from different isogenic
organs to iPSCs with respect to DNA methylation. We developed
a protocol to isolate and culture primary cells from different
human fetal organs at W21 and reprogrammed primary cells
from six different organs representing the three primary
embryonic germ layers: brain and skin (ectoderm), kidney and
muscle (mesoderm), and lung and pancreas (endoderm) (Fig. 4a,
b). After lentiviral reprogramming using POU5F1 (or OCT4),
KLF4, SOX2 and c-MYC45, two clones per iPSC line were
expanded and characterized (Fig. 4b, top-middle row). Immu-
nohistochemical analysis showed that all clones expressed the
pluripotency-associated markers POU5F1, TRA-1-81, NANOG
and SSEA4 (Fig. 4b bottom rows and Supplementary Fig. 4a).
Furthermore, (endogenous) POU5F1, NANOG and SOX2 were
also detected at the transcriptional level using real-time quanti-
tative PCR (Fig. 4c). From the 12 hiPSC clones generated, 11
clones showed normal karyotype (46,XY) and no major genomic
aberrations (Supplementary Fig. 4b). Clone #2 derived from the
lung acquired an unbalanced translocation involving chromo-
some X and 16, der(16)t(X;16), in all cells examined (25 meta-
phases) (Supplementary Fig. 4b).
Epigenetic memory in human iPSCs generated from brain
tissue. To determine whether differences in residual DNA
methylation were evident between each isogenic organ and its
derivative hiPSC clones (epigenetic memory), the DNA methy-
lation profiles obtained for each of the hiPSC lines generated (two
different clones per line) were compared with the organ of origin.
The total DNA methylation distribution showed that the hiPSCs
were more hypermethylated than their organ of origin (Fig. 4d).
Hierarchical clustering using the DNA methylation datasets
revealed a separation between the 12 hiPSC clones and their
isogenic tissue counterparts (Fig. 4e). We included two previously
published 450 K datasets of human pluripotent stem cells (in total
n= 39 hiPSCs and n= 32 hESCs)5, 46 in the comparison and
observed that the different hESCs and hiPSCs lines clustered
together (Supplementary Fig. 4d) indicating that general patterns
of DNA methylation of all lines studied might be comparable.
To explore this further, we looked for a hiPSC-specific DNA
methylation barcode by comparing the CpG methylation levels of
our hiPSC clones to that of the six tissues of origin (Fig. 4f). We
found 8772 hypermethylated (> 0.2 delta beta) and 2952
hypomethylated (< 0.2 delta beta) CpGs common to all 12 iPSC
clones (Supplementary Data File 5), underlining the role of DNA
methylation during reprogramming towards pluripotency47. The
hypermethylated and hypomethylated CpGs identified in our
hiPSC clones showed comparable methylation levels in the large
majority of the samples from two external datasets analyzed5, 46
(Supplementary Fig. 4d), suggesting that the DNA methylation
pattern of hiPSC-specific CpGs could barcode other human PSCs.
Gene ontology analysis revealed that hypermethylated CpGs were
enriched in genes regulating cell adhesion, whereas hypomethy-
lated CpGs were enriched in genes regulating embryonic
morphogenesis and development (Supplementary Data File 6).
Next, we focused on the CpGs that were hypermethylated
(> 0.2 delta beta) or hypomethylated (< 0.2 delta beta) in each
triplet (organ of origin and the two associated hiPSC clones)
compared to the other five triplets, which would reflect organ-
specific epigenetic memory. Surprisingly, only the brain-triplet
contained distinctive methylated CpGs: 18 hypermethylated and
6 hypomethylated CpGs (Fig. 4g). However, 7 of the 18 brain-
triplet hypermethylated CpGs were mapped to the gene bodies of
BTBD17, a protein-coding gene overexpressed in fetal and adult
brain37, 48; ANO8, a Ca2+-activated chloride channel expressed in
the human brain37, 49; and SEMA5B, a semaphorin associated
with axon development50; and 3 of the 6 brain-triplet
hypomethylated CpGs mapped to the proximal promoter of
MKRN3-AS1, an antisense RNA that is overexpressed in brain
and spinal cord37. Those genes as well as the genic location of the
CpGs, i.e. gene bodies for hypermethylation and proximal
promoters for hypomethylation, suggested that there is a small
degree of brain-specific residual epigenetic memory in the brain-
hiPSCs.
To test the functionality of the brain-specific residual
epigenetic memory in the brain-hiPSCs, we differentiated both
clones of the brain-hiPSCs and skin-hiPSCs to the neural lineage
(Supplementary Fig. 4e). After 7 days of differentiation, the brain-
and skin-hiPSCs generated similar percentages of embryoid
bodies composed of at least 50% of neural rosettes (Supplemen-
tary Fig. 4f). However, the brain-hiPSC culture showed higher
TUBB3 expression and less SOX9 expression than the skin-hiPSC
culture, suggesting higher neural differentiation propensity
(Supplementary Fig. 4g). Indeed, after 12 days of differentiation,
the brain-hiPSC culture showed more TUBB3 expression
(Supplementary Fig. 4g) and contained more GFAP-positive
neural derivatives (Supplementary Fig. 4h) than the
skin-hiPSC culture. In summary, both the brain-hiPSCs and
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skin-hiPSCs differentiate to neural derivatives, but the brain-
hiPSCs did so with slightly higher propensity.
Discussion
In this study, we generated a human atlas consisting of large
number of DNA methylation (n= 105 samples) and tran-
scriptome (n= 111 samples) profiles of human fetal organs from
18 individuals, at matched gestational time points (W8-12, W16-
18, W20-22).
The analyses of the transcriptional datasets allowed us to
identify DEGs that were upregulated or downregulated in an
organ- and developmental stage-specific manner. We further
compared these differences in gene expression with changes in
DNA methylation per organ analysed. Organ-specific down-
DEGs, in particular in the eye, muscle and liver, associated with
increased DNA methylation in their proximal promoters and
decreased DNA methylation in their gene bodies, in line with
previous findings using hESCs, fibroblasts and monocytes51.
Organ-specific up-DEGs were accompanied by decreased DNA
methylation in their proximal promoters and increased DNA
methylation in their gene bodies in amnion, eye and pancreas.
This modest correlation between up-DEGs and DNA methylation
changes may be partly explained by the fact that many CpGs in
proximal promoters are unmethylated, independent of tran-
scriptional state of each loci.
Our isogenic sets of 14 organs from W9, W18 and W21 pro-
vided us with the organ-specific DNA methylation pattern and
revealed its dynamics between W9 and W21. Future studies using
further improvements in technology to investigate genome-wide
DNA methylation and transcription simultaneously at the single-
cell level will increase the resolution from organ to specific pro-
genitor cell types of interest52, 53.
We succeeded in deriving hiPSCs from six isogenic organs
(brain, skin, kidney, muscle, lung and pancreas) from W21, a
gestational time point with pronounced organ-specific differences
in both hypermethylation and hypomethylation of DMRs. Our
results suggest that the 12 hiPSC clones derived were comparable
with respect to global DNA methylation to other human PSCs
and different from the organs of origin.
Taking advantage of the experimental setup with a large
number of organs using the same primary cell isolation method,
culture protocol and reprogramming conditions, we finally
investigated whether DNA methylation would relate isogenic
derivative hiPSC clones to their organs of origin (epigenetic
memory). We observed that the brain-hiPSC clones retained 18
hypermethylated and 6 hypomethylated CpGs that were brain-
specific. This could be an underestimate due to the nature of the
platform used. Notably, the nearest loci of those CpGs did not
appear to be random and 11 of them were associated with four
genes (ANO8, BTBD17, SEMA5B, MKRN3-AS1) having a neural
context. In addition, the fact that the other organ-derived hiPSCs
did not show residual DNA marks relating them to their organ of
origin, but rather resembled skin-hiPSCs may suggest that the
reprogrammed cells may have been fibroblasts or stromal cells
independent of the organ of origin. In future studies, we would
consider reprogramming either more homogeneous somatic cells
or defined cell types. Nevertheless, when subjected to the same
directed differentiation protocol, the brain-hiPSCs and skin-
hiPSCs showed different propensity to form neural derivatives.
This difference in differentiation propensity, perhaps caused by
the limited epigenetic memory of the brain-hiPSCs, suggested
that this phenomenon should be more extensively studied as it
may have implications in the use of human iPSCs in biomedical
applications54, 55: the tissue of choice from which to derive
patient-specific hiPSCs and the retention of specific DNA
methylation marks may determine the success of each specific
application (type of drug-testing, type of disease modeling or
tissue repair). Furthermore, it would be interesting to reprogram
non-isogenic cells from the same tissue in order to investigate to
what extent the genetic component compared to the epigenetic
one has implications on the differentiation propensity of iPSCs.
Methods
Ethical statement. This study has been approved by the Medical Ethical Com-
mittee of the Leiden University Medical Center (P08.087). Informed consent was
obtained from all patients and was compliant with the Declaration of Helsinki
(World Medical Association).
Fetal tissue procurement and primary cell culture. Human fetal organs used for
DNA extraction were processed as follows: after washing with 0.9% NaCl (Frese-
nius Kabi, France), the identified organs were immediately snap-frozen and stored
at −80 °C8. For primary cell culture, pieces of human fetal organs were minced with
a scalpel (Swann Morton, Sheffield, UK) and each transferred to gelatin-coated
wells of 6-well plates with isolation medium (Dulbecco’s Modified Eagle Media
(DMEM)/F12 supplemented with Glutamax (Gibco, Bleiswijk, the Netherlands),
10 mM NEAA, 2 mM L-glutamine, 25 U per ml penicillin,
25 mg per ml streptomycin, 50 µg per ml gentamicin, 100 mM b-mercaptoethanol
(all Invitrogen, Breda, The Netherlands), 25 µg per ml normocin (Invivogen, San
Diego, USA), 20% knock-out serum replacement (KOSR; Invitrogen, Breda, the
Netherlands)). After two days, the medium was changed and one day later, the cells
were washed with Dulbecco’s phosphate buffered saline (DPBS, Gibco) and fresh
isolation medium was added. After six to seven days, the cells were trypsinized
using 0.25% Trypsin-EDTA (Gibco) and frozen in freezing medium (80% isolation
medium, 10% KOSR, 10% DMSO (Sigma-Aldrich, St. Louis, USA)).
Generation of hiPSCs. To reprogram the fetal cells, the pRRL.PPT.SF.hOKS-
MidTomato-preFRT polycistronic lentiviral vector was used45. Briefly, 2 × 104 cells
per 12-well plate well were plated and transduced the following day with the
lentivirus at 1-2 MOI in isolation medium supplemented with 4 µg per ml poly-
brene (Sigma-Aldrich, St. Louis, USA). After 24 h, the medium was changed and
three days later, all the cells were split 1:1 or 1:2 (depending on the fluorescence
intensity) into 60 mm dishes coated with mouse embryonic fibroblasts (MEFs;
7.2 × 105 MEFs per dish). After culturing the transduced cells in isolation medium
for one day, the medium was changed to hiPSC medium (Dulbecco’s Modified
Eagle Media (DMEM)/F12 supplemented with Glutamax, 10 mM NEAA, 25 U per
ml penicillin, 25 mg per ml streptomycin, 100 µM b-mercaptoethanol, 20% knock-
out serum replacement and 10 ng/ml basic FGF (PreproTech
Neuilly-Sur-Seine, France)). After manual picking, hiPSC-like colonies were cul-
tured for one to three passages and then either frozen in 90% fetal calf serum
(Sigma-Aldrich) and 10% DMSO (Sigma-Aldrich) or further expanded on Matrigel
(Corning, Wiesbaden, Germany) in mTESR1 (Stem Cell Technologies, Grenoble,
France).
Characterization and neural induction of hiPSCs. Immunocytochemistry was
performed following standard procedures. Briefly, cells were fixed in 4% (w/v)
paraformaldehyde (PFA, MERCK, Darmstadt, Germany) for 15 min at room
temperature (RT). Subsequently, the cells were first permeabilized using 0.1%
Triton X-100 (Sigma-Aldrich, St. Louis, USA) and then blocked with 1% bovine
serum albumin, fraction V (BSA, Sigma-Aldrich) in 0.05% Tween-20 (Promega,
Madison, USA) for 1 h. The following primary antibodies were then applied
overnight at 4 °C: Goat anti-OCT4 (Stock 0.1 mg per ml, 1:100, SC-8628, Santa
Cruz Biotechnologies, Dallas, USA), mouse anti-TRA-1-81 (Stock 1 mg per ml,
1:100, MAB4381, Millipore, Bedford, USA), mouse anti-SSEA4 (Stock 0.2 mg per
ml, 1:100, SC-59368, Santa Cruz Biotechnologies), rabbit anti-NANOG (Stock 0.5
mg per ml, 1:250, 09-0020, Stemgent, San Diego, USA). The secondary antibodies
Alexa Fluor 488 donkey anti-rabbit (Stock 2 mg per ml, 1:500, A-21206, Life
Technologies, Carlsbad, USA), Alexa Fluor 488 donkey anti-goat (Stock 2 mg per
ml, 1:500, A-11055, Life Technologies), and Alexa Fluor 594 donkey anti-mouse
(Stock 2 mg per ml, 1:500, A-21203, Life Technologies) were added for 1 hour at
RT and the nuclei were counterstained using 4′,6-diamidino-2-phenylindole
(DAPI, Life Technologies). Imaging was performed on an Eclipse Ti imaging
system (Nikon, Tokyo, Japan) operated by NIS Elements software and compiled in
Photoshop CS6 (Adobe Systems Inc., San Jose, USA).
RNA from the hiPSCs was extracted with the RNeasy Kit (Qiagen, Hilden,
Germany) including on-column DNase digestion, followed by cDNA generation
with the iScript™ cDNA Synthesis Kit (BioRad, Hercules, USA). Quantitative PCR
was carried out on the CFX96TM Realtime system, C1000TM Thermal Cycler
(Biorad) using the iQ SYBR Green Supermix (BioRad) and the following program:
(1) 3 min. 95 °C; (2). 40 cycles 15 s 95 °C; 30 s 60°C, 45 s 72 °C; and (3) 10 s 95 °C; 5
s 65 °C, 50 s 95 °C). The ΔΔCt method and normalization to GAPDH and ACTB
was used to assess expression levels. The expression levels of hiPSCs were
compared to those of the hESC-NKX2.5eGFP/w line, which was used as positive
control56. The primer sequences are: ACTB - Fw CTG GAA CGG TGA AGG TGA
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CA and Rv AAG GGA CTT CCT GTA ACA ACG CA; GAPDH - Fw CTG CAC
CAC CAA CTG CTT AG and Rv GTC TTC TGG GTG GCA GTG AT; POU5F1
endogenous – Fw GAC AGG GGG AGG GGA GGA GCT AGG and Rv CTT CCC
TCC AAC CAG TTG CCC CAA AC; NANOG - Fw TGC AAG AAC TCT CCA
ACA TCC T and Rv ATT GCT ATT CTT CGG CCA GTT; SOX2 endogenous –
Fw GGG AAA TGG GAG GGG TGC AAA AGA GG and Rv TTG CGT GAG
TGT GGA TGG GAT TGG TG13, 57, 58.
The karyotypes of the 12 hiPSC lines were assessed using combined binary ratio
labelling (COBRA)59. Briefly, glass slides containing air-dried metaphase spreads
were incubated with 100 µg per ml RNase I (Roche, Woerden, the Netherlands) in
2 x Saline-Sodium Citrate (SSC, Sigma-Aldrich, St Louis, USA) at 37 °C for 10 min,
followed by incubation with 0.005% pepsin (Sigma-Aldrich) in 0.1 M HCl for 5
min at 37 °C and treatment with 1% formaldehyde (Sigma-Aldrich) in PBS at RT
for 10 min. After hybridization with the chromosome-painting probe pools for
40–72 h, slides were washed in 2 x SSC; and 0.1% Tween-20 (Promega, Madison,
USA) in 2 x SSC. The chromosomes were visualised using a Leica DMRA
fluorescence microscope (Leica, Wetzlar, Germany) with the CoolSnap HQ2
camera (Photometrics, Tucson, USA), and the COBRA-FISH software (Applied
Imaging, San Jose, CA).
Neural induction of hiPSCs was performed using the Stemdiff Neural System
(Stemcell Technologies, Catalog #05835, Vancouver, Canada) according to
manufacturer’s instructions. Briefly, embryoid bodies (4000 cells per embryoid
body) were grown for 4 days and subsequently plated on matrigel-coated dishes.
Cells were analysed by dark-field microscopy and scored for the presence of neural
rosettes at day 7 (% EBs composed of at least 50% rosettes, N= 3). After 7 and
12 days of neural differentiation, cells were fixed with 4% PFA (20 min, RT) and
used for immunofluorescence as above, using as primary antibody rabbit
anti-GFAP (Stock 2.9 mg per ml, 1:200, Z0334, DAKO, Heverlee, Belgium), rabbit
anti-SOX9 (Stock 1 mg per ml, 1:200, AB5535, Millipore, Bedford, USA) and
mouse anti-TUBB3 (Stock 1 mg per ml, 1:200, AB78078, Abcam, Cambridge, UK)
and as secondary antibody Alexa Fluor 488 donkey anti-rabbit (Stock 2 mg per ml,
1:500, A-21206, Life Technologies, Carlsbad, USA) and Alexa Fluor 594 donkey
anti-mouse (Stock 2 mg per ml, 1:500, A-21203, Life Technologies). Quantitative
PCR for neural markers was performed as described above and the data were
presented as mean± standard deviation of technical triplicates. Statistical analysis
was performed by a Student’s t-test (two-tailed) using the statistical software
package SPSS 20.0 (SPSS Inc., Chicago, IL, USA). p< 0.05 was considered
significant. TUBB3–Fw GGC CAA GGG TCA CTA CAC G and Rv GCA GTC
GCA GTT TTC ACA CTC; SOX9–Fw AGC GAA CGC ACA TCA AGA C and Rv-
CTG TAG GCG ATC TGT TGG GG.
DNA extraction and 450 K array data processing. The genomic DNA (gDNA)
of the different organs was extracted as previously described8. Briefly, after
homogenization, lysis with proteinase K (600 mAU per ml, Qiagen, Hilden, Ger-
many), and degradation of residual RNA using RNase A (10 mg per μl, Invitrogen,
Carlsbad, USA), gDNA was extracted on phenol/chloroform basis with Phase Lock
Heavy Gel 2 ml Eppendorf tubes (5PRIME, Hilden, Germany). For the hiPSCs
(from passage 10-14), the Wizard Genomic DNA Purification Kit (Promega, Lei-
den, the Netherlands) was used following manufacturer’s
instructions60. In addition to the Nuclei Lysis Solution of the kit, proteinase K
(Qiagen) was added to lyse the cells followed by removing the remaining RNA with
RNase A. The gDNA was quantified using the Qubit dsDNA BR Assay Kit on a
Qubit 2.0 Fluorometer (Sigma-Aldrich, St Louis, USA). An average input of 600 ng
was used for bisulfite conversion with the EZ-96 DNA methylation kit (Zymo
Research, Orange County, USA). Subsequently, the DNA methylation profiles were
determined with the Illumina HumanMethylation450 BeadChip according the
manufacturer’s protocol.
The package minfi61 was used to import the data in R version 3.2.2. To
normalize the data, a custom pipeline was used8, 62, 63. Briefly, after filtering probes
with a low bead count ( < 3), high detection p-value (> 0.01), and with a low
success rate ( < 95%), and ambiguously mapped probes, background correction
and color correction were applied. Eventually, the data was normalized using
functional normalization as implemented in the minfi package61. For all the
analyses, except for the DNA methylation profiles of isogenic samples, the probes
in CG SNPs (with an allele frequency> 5%) as well as CG probes on the sex
chromosomes were excluded64. The DNA methylation data of the fetal organs (n=
105 samples) and the stem cells (n= 12 hiPSC and n= 6 organs) were normalized
separately.
Bioinformatic analyses. The R package ggplot2 2.0.0 was used for plotting65.
Gene expression data: Gene expression data was downloaded from the Gene
Expression Omnibus (GEO) database (GSE66302)7 and was normalized with the R
package edgeR 3.2.47, 66, 67. Briefly, after applying a cutoff value of four reads, the
data was normalized with the weighted trimmed mean of M values (TMM)
method. The multi-dimensional scaling plots were also generated with R package
edgeR 3.2.4.
DNA methylation data: A genic and CGI-centric annotation was used for the
450 K CpG probes8, 35. Briefly, the genome was divided into five regions for the
genic annotation: the intergenic region (> 10 kb from the nearest TSS), the distal
promoter (−10 to 1.5 kb from the nearest TSS), the proximal promoter (−1.5 kb to
+ 500 bp from the nearest TSS), the gene body ( + 500 bp to 3′ end of the gene) and
the downstream region (3′ end to + 5 kb from 3′ end). For the CGI-centric
annotation, the genomic locations of CpG islands were downloaded from the
UCSC browser68, and the CpGs were assigned as non-CGI, CGI, CGI shore or CGI
shelf. For both, multidimensional scaling and clustering, Euclidian distance was
used. For the clustering, average linkage was applied.
Differential expression and correlation with methylation: The differentially
expressed genes between W8-12 and W20-22 (with W16-18 in between), were
identified with R package edgeR 3.2.4 using a FDR< 0.0166, 67. For the organs that
only had one replicate at one or more time points, the mean of all biological
coefficients of variation (BCVs) of the organs with at least two replicates at all three
time points was used as dispersion value. The CpGs in the nearest proximal
promoters and gene bodies of all uniquely differentially expressed genes per organ
were selected and the difference in beta value between W8-12 and W20-22 was
calculated.
Hypermethylation and hypomethylation: Relative hypermethylated and
hypomethylated CpGs were defined as pairwise difference of> 0.2 or< 0.2 in beta
values, respectively, in the sample of interest compared to the other samples.
Chromatin state segmentations: Chromatin state segmentations for the available
organs (fetal adrenal, amnion, fetal heart atrium and ventricle, fetal intestine, fetal
kidney, adult liver, fetal lung, fetal muscle, adult pancreas, placenta, adult
fibroblasts (skin), fetal stomach) were downloaded from the Epigenomics Roadmap
Project42. The enrichment was calculated as odds ratio (OR).
Differentially methylated regions: Organ-specific DMRs were identified as
previously described8, 35. Briefly, DMRs were defined by three consecutive CpGs
sharing a common feature (hyper- or hypomethylation) with a maximum of 1 kb
between them and not more than three CpGs that did not have the common
feature.
External data. Gene expression and DNA methylation data were downloaded
from NCBI’s Gene Expression Omnibus (GSE663027; GSE565158; GSE306545;
GSE6146146).
Data availability. All data are available and have been deposited in the NCBI’s
Gene Expression Omnibus under the accession number GSE76641.
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